SYRE Stock Performance and Key Statistics

SYRE has a current P/E ratio of -45.23

The SYRE stock has a trailing twelve month price-to sales (P/S) ratio of 65.81 while its price-to-book (P/B) value is 50.86.

SYRE's price-to-free-cashflow (P/FCF) ratio is -32.05, an indicator that is currently being trending upward.

Based on SYRE's recent bid, its distance from 20 days simple moving average is 17.76%. It is 26.25% apart from 50 days simple moving average, and it is 89.11% apart from 200 days simple moving average.

The 52-week high for SYRE is $101.70 which is -5.7% away from the current price level whereas the distance of that from the 52-week low of $14.00 stands at 295.51%.

The performance of SYRE stock was not encouraging with most of its significant price indicators in green. Spyre Therapeutics, Inc.(NASDAQ: SYRE) shares have moved upward +13.56% or $11.98 in the latest trading session and have gained 2.96% year-to-date (YTD). The stock has gained nearly 64.14% over the past year. After moving 50.11% over the trailing 3-month period, the stock is 106.3% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 2.84% a week and 2.03% a month.

The current 14-day RSI for SYRE stock is 71.88. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Spyre Therapeutics, Inc. (SYRE) has a 14-day ATR of 2.22.

After closing at $88.34 with 60.4M of its shares outstanding, the current enterprise value of SYRE is roughly -.

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is up 64.14% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 10.67%. SYRE stock price is also up 2.96% on its value in year-to-date trading.

The number outstanding shares of SYRE is 60.4M, and of these 77.38% shares are freely available for trading. On average, SYRE stock has traded 2.02M shares per day for the past 10 days. A total of 2.77M shares changed hands during the last trading session with the average session volume of 1.21M shares.